Patients with non-small cell lung cancer (NSCLC) often respond to standard chemotherapy, only to develop drug resistance later, and with fatal consequences. But what if doctors could identify those at greatest risk of relapse and provide a therapy to...
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2rYVeVP
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Hedgehog signalling pathway orchestrates angiogenesis in triple-negative breast cancers British Journal of Cancer 116, 1425 (23 May 2017). ...
-
Publication date: April 2017 Source: European Journal of Cancer, Volume 75 Author(s): A. Ieni, G. Angelico, P. Zeppa, G. Tuccari fro...
-
Objective A systematic review and meta-analysis to investigate the impact of electronic nicotine delivery systems (ENDS) and/or electronic n...
-
Publication date: October 2017 Source: International Journal of Biological Macromolecules, Volume 103 Author(s): Shehwaz Anwar, Hina Youn...
-
BACKGROUND AND PURPOSE: Feasibility of brain atrophy measurement in patients with MS in clinical routine, without prior standardization o...
-
Publication date: Available online 13 May 2017 Source: Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms Author(s): Ping Li...
-
Related Articles Characteristic MR Imaging Findings of the Neonatal Brain in RASopathies. AJNR Am J Neuroradiol. 2018 Apr 05;:...
-
Publication date: June 2017 Source: International Journal of Biological Macromolecules, Volume 99 Author(s): Ayumu Ohyama, Taishi Higashi...
-
The peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription factors of the nuclear receptor superfamily. Upon...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου